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The agr locus of Staphylococcus aureus is composed of two divergent transcripts (RNAII and RNAIII) driven
by the P2 and P3 promoters. The P2-P3 intergenic region comprises the SarA/SarR binding sites and the four
AgrA boxes to which AgrA binds. We reported here the role of AgrA, SarA, and SarR on agr P2 and P3
transcription. Using real-time reverse transcription (RT)-PCR and promoter fusion studies with selected
single, double, triple, and complemented mutants, we showed that AgrA is indispensable to agr P2 and P3
transcription, whereas SarA activates and SarR represses P2 transcription. In vitro runoff transcription assays
revealed that AgrA alone promoted transcription from the agr P2 promoter, with SarA enhancing it and SarR
inhibiting agr P2 transcription in the presence of AgrA or with SarA and AgrA. Electrophoretic mobility shift
assay (EMSA) analysis disclosed that SarR binds more avidly to the agr promoter than SarA and displaces
SarA from the agr promoter. Additionally, SarA and AgrA bend the agr P2 promoter, whereas SarR does not.
Collectively, these data indicated that AgrA activates agr P2 and P3 promoters while SarA activates the P2
promoter, presumably via bending of promoter DNA to bring together AgrA dimers to facilitate engagement of
RNA polymerase (RNAP) to initiate transcription.
Staphylococcus aureus is an opportunistic pathogen that
causes a broad range of human infections in both community
and hospital settings (17, 22). In most cases, infections begin as
a localized lesion and then spread to the bloodstream. Once
the infection is in the bloodstream, patients are at risk for
developing endocarditis and other metastatic complications
(11).
The pathogenicity of S. aureus is a complex process that
involves the coordinated expression of many virulence factors,
which can be divided into two main categories, based on their
functions either as surface protein adhesins or as secreted
toxins and enzymes. Typically, surface protein adhesins are
produced during the exponential phase of growth. The second
stage of infection, analogous to the post-exponential phase of
growth, is characterized by enhanced toxin and enzyme pro-
duction, eventually leading to tissue destruction and bacterial
spread (22). The regulatory events controlling the transition
from the exponential phase to the post-exponential phase of
growth are mediated in part by agr, which, upon activation,
represses surface protein expression and promotes secretion of
extracellular toxins (25).
The agr locus is composed of two divergent transcripts called
RNAII and RNAIII. RNAII encodes four genes (agrDBCA),
with AgrD encoding a 46-residue peptide which is processed
into a cyclic autoinducing peptide (AIP) and then exported by
AgrB (25). Upon accumulation of AIP with increasing cell
density, it induces phosphorylation of AgrC, a membrane sen-
sor within a two-component regulatory system, followed by a
second-step phosphorylation of the response regulator AgrA
(25). AgrA can then bind to specific direct repeats in the
intergenic region between the RNAII and RNAIII promoters
to modulate agr transcription (18). Activation of RNAIII, the
agr effector molecule, results in repression of many surface-
associated proteins while promoting exoprotein gene transcrip-
tion and, to a lesser extent, translation (13, 25).
Besides AgrA, a number of regulators controlling agr ex-
pression have been described (5, 7). Among these is SarA, a
14.7-kDa DNA binding protein that is a prototypic member
of a family called the SarA protein family (6, 7). Most, if not
all, members of the SarA protein family are winged helix
proteins that bind to target promoters to alter virulence
gene expression (7, 21). Indeed, DNA binding studies re-
vealed that SarA can bind to the agr P2 and P3 promoters (8,
30). Transcription studies of S. aureus cells in vivo have
consistently shown that SarA upregulates RNAII expression
(8, 9); however, in vitro transcription analysis of the agr P2
promoter in the presence of SarA alone revealed repression
rather than activation (3). This discrepancy between in vivo
activation and in vitro repression of the agr P2 promoter by
SarA has not been explained until now.
SarR is a 13.6-kDa protein that is also a member of the SarA
protein family. In vitro, SarR can bind to the agr promoter to
influence agr transcription in S. aureus strain RN6390 (23), a
strain with a defective rsbU gene which is required for the
optimal expression of the stress-induced alternative sigma fac-
tor called SigB (19, 28). Using real-time reverse transcription
(RT)-PCR and transcriptional fusion analyses of a deletion
mutant (without an antibiotic marker) in strain SH1000 (rsbU-
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restored variant of RN6390), we have recently shown that
SarR can downregulate agr RNAII expression in strain SH1000
(34), different from what we have discerned with the sarR
mutant of strain RN6390 (rsbU mutant) in which RNAII tran-
scription was slightly elevated compared with that of the par-
ent. The binding site of SarR on the agr promoter, located
between the P2 and P3 promoters, shares an overlap with that
of SarA (8, 24) (Fig. 1).
Given the temporal regulation of agr by SarR and SarA and
the effect of AgrA on its cognate promoter, we wanted to
investigate the role of AgrA, SarA, and SarR on transcription
from the agr P2 and P3 promoters, using deletion mutants
generated without any replacement antibiotic marker but con-
taining intact promoter and transcription termination signals.
Our data showed that AgrA is essential to transcriptions from
the agr P2 and P3 promoters. More specifically, the AgrA
promoter boxes and the overlapping SarA and SarR binding
sites between the P2 and P3 promoters (Fig. 1) are critical to
agr P2 transcription but not P3 transcription. Using in vitro
runoff transcription assays, we found that SarA, in the presence
of AgrA, promotes transcription from the agr P2 promoter in
vitro, while SarR acts as a repressor. Electrophoretic mobility
shift assay (EMSA) and promoter DNA bending assays suggest
that SarA and AgrA bind and bend the agr P2 promoter,
whereas SarR displaces SarA and binds but does not bend the
promoter, thus providing a mechanism by which SarA and
SarR modulates the agr P2 promoter activity via DNA bending
in the presence of AgrA.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. S. aureus strains used in
this study, listed in Table 1, are derivatives of SH1000, an rsbU-restored strain of
the 8325-4 strain (15). Growth of S. aureus was conducted in tryptic soy broth
(TSB; Difco) supplemented with erythromycin (3 or 10 g/ml, depending on the
copy number of the erythromycin cassette) as needed. Gene deletions of strain
SH1000 for sarA and sarR were carried out using the temperature-sensitive
pMAD plasmid as described previously (1, 36). For the agrA mutant, we intro-
duced translation stops (TAATGA) right next to the start codon to ensure that
AgrA was not translated without any interruption of RNAII transcription, using
pMAD. A similar technique was used to replace the deleted gene with a wild-
type copy. Escherichia coli DH5 was the vehicle for routine DNA manipulation.
Shuttle vector pALC1484, a derivative of pSK236 containing the gfpuvr reporter
gene (16), was used to construct promoter DNA-green fluorescent protein
(GFP) reporter fusions. For growth in E. coli, Luria-Bertani (LB) broth was
routinely used; ampicillin was added to a final concentration of 50 g/ml as
needed. For growth in S. aureus, chloramphenicol at 10 g/ml was used in TSB.
Growth was monitored at 37°C at an optical density at 650 nm (OD650) with a
Spectronic 20D spectrophotometer (Spectronic Analytical Instruments, Gar-
forth, England), using 18-mm borosilicate glass tubes.
Promoter DNA-GFP reporter assay. Promoter-GFP reporter fusions were
constructed by inserting the agr promoter fragments into the EcoRI and XbaI
sites of pALC1484 (16). Recombinant plasmids were then transformed first into
S. aureus strain RN4220 for proper methylation followed by introduction into the
wild-type, mutant, and restored strains of SH1000 derivatives as described pre-
viously (33). Overnight cultures were diluted 1:500 into 10 ml of TSB containing
chloramphenicol (10 g/ml) to yield an OD650 of 0.01 and grown at 37°C with
constant shaking at 250 rpm. Fluorescence (excitation/emission  485/515 nm)
was then monitored with an FL600 fluorescence spectrophotometer (Biotek,
Winooski, VT) every 2 h and reported as fluorescence units/OD650 values.
RNAP purification. For purification of native RNA polymerase (RNAP) from
S. aureus, a DNA insert bearing the His10 tag at the C terminus of rpoC was
cloned into the pMAD vector and introduced into the chromosome of a sarA
agrA sarR triple mutant of SH1000. RNAP was then purified from 3 liters of cells
grown in TSB to an OD600 of 1.0. Briefly, cells were harvested by centrifuga-
tion, followed by freezing overnight at 80°C. Cells were then suspended in 30
ml lysis buffer (50 mM Tris-HCl [pH 8.0], 100 mM NaCl, 5 mM MgCl2, 5 mM
-mercaptoethanol, 1 mM phenylmethylsulfonyl fluoride [PMSF], and 20% glyc-
erol) and lysed with four passages through a French press followed by clarifica-
tion of the lysate with centrifugation (14,000 rpm, 30 min). RNAP was then
purified by passaging the clear lysate through 10 ml of Ni-nitrilotriacetic acid
(Ni-NTA) in a column (Qiagen), washing the resin with 10 volume of lysis
buffer with 50 mM imidazole, followed by elution with 50 ml of elution buffer
(similar to lysis buffer but with 250 mM NaCl) containing 500 mM imidazole. The
eluted RNAP was concentrated with Amicon Ultracel-10K (Millipore), dialyzed
with buffer containing 10 mM Tris-HCl (pH 8.0), 100 mM KCl, 5 mM MgCl2, and
20% glycerol using a Slide-A-Lyzer dialysis cassette (Pierce), and stored at
20°C. The purities of various subunits within RNAP were confirmed by SDS-
gel analysis.
Purification of SarA, SarR, and AgrA proteins. Both sarA and sarR coding
regions are cloned into pET11b and pET14b, respectively, in E. coli
BL21(DE3)pLysS. Protein expression and purification were conducted as de-
scribed previously (8, 23). For AgrA protein purification, the agrA coding region
was cloned into the NdeI and SmaI sites of pTYB2 (New England BioLabs),
followed by transformation into BL21(DE3)pLysS cells. Cells grown in 1 liter of
LB and induced with 0.5 mM IPTG (isopropyl--D-thiogalactopyranoside) for
5 h were harvested by centrifugation, passed through a French press thrice, and
clarified by a second centrifugation step. The clarified lysate was loaded on a
chitin bead (NEB) column, and the AgrA protein was purified according to the
manufacturer’s protocol. For additional purification, the fractions of interest
were applied to a Bio-Rad High Q column and eluted with an NaCl gradient of
0.1 to 0.5 M. Fractions containing the AgrA were concentrated with Amicon
Ultracel-10K (Millipore) and dialyzed with 10 mM Tris-HCl (pH 8.0), 50 mM
NaCl, and 5% glycerol using a Slide-A-Lyzer dialysis cassette (Pierce).
In vitro runoff transcription assay. Linear DNA templates of rpsD (control
template) and agr P2 and P3 promoters were generated by PCR. In vitro tran-
scription experiments were carried out as follows: the promoter DNA template
(20 nM) was incubated with 50 nM RNAP with or without AgrA, SarA, or SarR
(as indicated) in buffer containing 10 mM Tris-HCl (pH 8.0), 50 mM NaCl, 5 mM
MgCl2, and 50 g/ml of bovine serum albumin (BSA) for 10 min at room
temperature. To initiate the reaction, a nucleotide mixture containing 200 M
(each) ATP, GTP, and CTP, 10 M UTP, and 10 Ci [-32P]UTP was added to
the reaction mix and incubated at 37°C, and then the reaction was terminated
after 15 min with the addition of 10 l of stop solution (1 M NH4CH3COO, 30
mM EDTA, and 100 g/ml yeast tRNA). The reaction mixture was ethanol
precipitated and resolved in an 8% urea-PAGE gel. Images were scanned using
FIG. 1. The intergenic sequence between the agr P2 and P3 pro-
moters. There are 186 bp between the two transcription start sites
(labeled with bent arrows). The 10 and 35 promoter boxes for P2
and P3 promoters are depicted on top of the sequence. The AgrA
tandem repeats are indicated by long bold arrows (the set below is
complementary to the top set). The SarA and SarR binding sites,
located between the two sets of tandem repeats, share a partial over-
lap, with the SarA binding site (palindromic sequence) highlighted by
dotted lines and the SarR binding site boxed. The 10 promoter box
for the P3 promoter has an extended 10 sequence (TGT), which may
reduce the requirement for the canonical 35 promoter motif (14).
The intergenic agr P2-P3 sequence here is conserved in 6 published S.
aureus genomes. The difference between this sequence and divergent
ones in other S. aureus genomes resides primarily in one base change
(marked with an asterisk) downstream of the 10 promoter box of the agr
P2 promoter, with a C replaced by a T.
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Molecular Dynamics Typhoon 8600 (GE Healthcare) and processed using Im-
ageQuant version 5.2.
RNA extraction and real-time RT-PCR. Cells of wild-type or mutant strains
grown in TSB to mid-, late, and post-exponential phases were harvested at 4,000
rpm for 10 min (4°C) and stored overnight at 80°C. Cells were then suspended
in 350 l of TRIzol (Invitrogen), mixed with glass/zirconia beads, and lysed with
a reciprocating shaker (BioSpec). Final steps of RNA extraction and purification
were carried out using a RiboPure-bacteria RNA purification kit (Ambion/
Applied Biosystems, Austin, TX) as described in the manufacturer’s insert. To
remove residual DNA, RNAs were treated with RNase-free DNase I, provided
in the kit.
For real-time RT-PCR, 1 g each of RNA was used to generate cDNA via
reverse transcription using a Roche first-strand transcriptor kit (Roche, Mann-
heim, Germany). Using a SYBR green I master kit (Roche, Mannheim, Ger-
many), cDNAs were analyzed and quantified in a LightCycler 480 instrument
(Roche) according to the manufacturer’s instructions, using gene-specific prim-
ers. The list of primers is available from the authors upon request. Data were
reported as agrB and RNAIII expression levels normalized to those of gyrB.
EMSA analysis. The agr promoter fragment (102 bp), generated by PCR, was
labeled with [	-32P]ATP (Perkin Elmer) by end labeling one of the PCR primers
using T4 polynucleotide kinase (NEB) prior to PCR. The PCR product was then
resolved in a 6% nondenaturing gel and purified using an Elutip-d column
(Schleicher and Schuell). Binding reaction was carried out by mixing the labeled
probe (10,000 cpm) with increasing concentrations of the protein and incubat-
ing for 20 min at room temperature. For displacement analysis, the labeled probe
was allowed to bind initially either SarA or SarR prior to the addition of different
concentrations of the competing protein and incubated for another 20 min.
Complexes were resolved in a denaturing 6% urea-PAGE gel, and images were
scanned using Molecular Dynamics Typhoon 8600 (GE Healthcare).
DNA bending assays. Hybridized oligonucleotides containing the SarA and
SarR binding sites in the agr promoter or the AgrA P2 tandem site were cloned
into the SacI-BglII site of the bending vector pCY7 (31) to yield plasmids
pAM1163 and pAM1847, respectively. Plasmids were digested with EcoRI,
HindIII, BstNI, EcoRV, NheI, and BamHI, and the fragments were purified and
labeled with [	-32P]ATP using T4 polynucleotide kinase. Labeled fragments
(5,000 cpm) were then mixed with and without SarA (0.5 mol), SarR (0.5
mol), or AgrA (25 nmol) in binding buffer containing 25 mM Tris (pH 7.5), 0.1
mM EDTA, 75 mM NaCl, 10% glycerol, 1 mM dithiothreitol (DTT), and 0.5 g
of sonicated calf thymus at room temperature for 20 min. The reaction mixtures
were then resolved in a 5% acrylamide gel, dried, and autoradiographed.
RESULTS
RNAII transcription in agrA, sarA, and sarR mutant strains.
Previous studies on transcriptional control of the agr locus in S.
aureus revealed that AgrA, SarA, and SarR likely play impor-
tant roles in regulating RNAII and RNAIII transcription.
However, the detailed events on how these proteins exert con-
trol on the agr P2 and P3 promoters (yielding RNAII and
RNAIII, respectively) and subsequently on downstream effec-
tor genes are not well understood. To address this question, we
constructed, using pMAD (1), single, double, and triple mu-
tants of agrA, sarA, and sarR in strain SH1000, a derivative of
strain 8325-4 with restored rsbU activity (15), by deleting the
respective coding regions without any antibiotic marker and
leaving the promoter and the transcription termination signal
intact. As for the agrA mutant, we introduced nonsense muta-
tions into Lys and Ile at positions 2 and 3 in the AgrA coding
region. We then analyzed by quantitative real-time RT-PCR,




RN4220 A mutagenized strain that accepts foreign DNA
RN6390 Laboratory strain related to strain 8325-4, rsbU mutant
SH1000 Strain 8325-4 with rsbU restored
ALC7075 SH1000 
sarA This study
ALC7076 SH1000 agrA mutant with agrATAATGA (denoted as agrATAATGA) This study
ALC7077 SH1000 
sarR This study
ALC7078 SH1000 agrATAATGA 
sarA This study





ALC7081 SH1000 agrATAATGA 
sarA 
sarR This study
ALC7082 SH1000 agrATAATGA 
sarA 
sarR rpoCHis10 This study
ALC7083 SH1000 
sarA/sarA complement This study
ALC7084 SH1000 agrATAATGA/agrA complement This study
ALC7085 SH1000 
sarR/sarR complement This study
ALC7086 SH1000 
sarR agrATAATGA/agrA complement This study
ALC7087 SH1000 
sarR 
sarA/sarA complement This study
E. coli strains










pTYB2 Expression vector with a self-cleavable intein tag NEB
pMAD E. coli-S. aureus shuttle vector containing temp-sensitive origin of replication bgaB, Ermr Ampr 1
pALC1484 E. coli-S. aureus shuttle vector derived from pSK236-containing multiple cloning site upstream
of the gfpuvr gene (a gfp variant), Amp
r Cmr 21
pALC1742-2 agr P2 promoter driving the expression of gfpuvr in pALC1484 This study
pALC1743-2 agr P3 promoter driving the expression of gfpuvr in pALC1484 This study
pCY7 Bending vector 31
pAM1163 pCY7 containing the SarA/SarR binding site This study
pAM1847 pCY7 containing the AgrA P2 tandem site This study
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using agrB and the sequence coding RNAIII as probes, the
transcription of RNAII and RNAIII in TSB-grown cells during
exponential, late exponential, and stationary phases (OD650 of
0.7, 1.1, and 1.7, respectively, as determined with 18-mm boro-
silicate glass tubes in a Spectronic 20D spectrophotometer
[Garforth, England]). As illustrated in Fig. 2A, the deletion of
agrA or sarA alone resulted in a significant decrease in RNAII
transcription in all three growth phases compared with that of
the parent. However, the effect was more dramatic with the
agrA mutant than with the sarA mutant, especially during the
late exponential and post-exponential phases (OD650 of 1.1
and 1.7). This finding is consistent with the notion that AgrA is
an important factor in expression from the agr P2 promoter.
The fact that deletion of sarA alone did not render the agr P2
promoter completely inactive implies additional genetic re-
quirement besides SarA for the optimal transcription from the
P2 promoter (37). Notably, the downregulatory effect of the
double sarA agrA mutation on RNAII transcription was similar
to that of the single agrA mutant, suggesting that the major
effect of sarA on RNAII expression is likely to be mediated via
AgrA. Interestingly, deletion of sarR triggered an upregulation
in RNAII transcription, with the effect more pronounced dur-
ing the late exponential phase (OD650 of 1.1), thus suggesting
that SarR acts as a repressor of the agr locus in the SH1000
background. However, strains bearing the sarR deletion in
combination with the agrA and/or sarA deletions did not ex-
hibit the aforementioned derepression, especially during the
late exponential phase, in contrast to what has been found with
the single sarR mutant, thus implying that derepression of
RNAII in the sarR mutant strain is likely dependent on intact
agrA and/or sarA loci.
We also confirmed these data by analyzing agr P2 promoter
fusion with GFPuvr (16). For the promoter fusion construct, we
have cloned a 235-bp P2 promoter fragment encompassing the
previously reported 4 putative AgrA boxes, the putative SarA
and SarR binding sites, and the core promoter elements (Fig.
1) upstream of gfpuvr in pALC1484. The recombinant plasmid
was introduced into various isogenic mutants of SH1000. To
minimize the variation in growth density, we normalized these
data to fluorescence units/OD650 values. As shown in Fig. 2B,
the activity of the agr P2 promoter was elevated in the sarR
mutant but was reduced in the isogenic sarA mutant compared
with that of the parental strain. In contrast, the agrA mutant,
the double agrA sarA, agrA sarR, and sarA sarR mutants, as well
as the triple mutant, all exhibited low levels of agr P2 promoter
activity, similar to that of the empty vector control.
To verify these data, we complemented agrA, sarA, and sarR
single mutants as well as the double agrA sarR and sarA sarR
mutants by replacing the deleted gene with a native copy using
pMAD and analyzing the ensuing agr P2 promoter activity with
GFP-mediated fluorescence. Our data showed that the pro-
portionately reduced P2 promoter activity levels in agrA and
sarA mutants were restored to wild-type levels upon comple-
mentation, while that of the sarR mutant was reduced to the
parental level (Fig. 2C). More importantly, both the agrA sarR
and sarA sarR double mutants, upon respective complementa-
tion with agrA and sarA, restored agr P2 promoter activity level
to that of the sarR mutant, at a level much higher than the
SH1000 parental strain. Taken together, the above results con-
cur with those of the quantitative RT-PCR data, strongly sug-
gesting that AgrA and, to a lesser extent, SarA activate agr
RNAII transcription, whereas SarR acts as a repressor, exert-
ing a greater impact on the later stage of growth. It should be
clarified that our data here on RNAII expression with the sarR
mutant of SH1000 (rsbU) differed from that reported for
RN6390 (rsbU mutant), where the sarR mutant exhibited
slightly lower RNAII expression than the isogenic parent (24).
Indeed, a direct comparison of P2 promoter activities using
promoter DNA-reporter fusions confirmed the discrepancy in
RNAII expression between sarR mutants of RN6390 and
SH1000 (data not shown). We speculate that reduced SigB
activity in strain RN6390 may conceivably impact RNAII ex-
pression and hence becomes a contributing factor to slightly
lower agr P2 activity in the sarR mutant in RN6390. In contrast
to RN6390, we have repeatedly found that RNAII transcrip-
tion in strain SH1000 was consistently elevated in the sarR
mutant compared with that of the isogenic parent.
SarR-mediated repression impacts the agr P2 but not the
agr P3 promoter. We also examined the effect of AgrA, SarA,
and SarR on the agr P3 promoter driving transcription of
RNAIII, which is the agr effector molecule (27). As with the agr
P2 promoter fusion constructs, the 219-bp agr P3 promoter
fragment encompassing the AgrA, SarA, and SarR binding
sites was fused upstream of the GFPuvr reporter gene in
pALC1484; the recombinant plasmid was then introduced into
various mutant strains of SH1000. Surprisingly, a mutation in
sarR, unlike the effect on the agr P2 promoter, did not lead to
any significant increase in agr P3 promoter activity compared
with that of the parent (Fig. 3A). A deletion of sarA resulted in
a notable decrease in agr P3 promoter activity in comparison to
the parent, whereas an agrA mutation rendered the same pro-
moter completely inactive. Reconstitution of the mutated sarA
or agrA gene with a wild-type copy in the chromosome restored
P3 promoter activity to the wild-type level, while complemen-
tation of the sarR mutant at the chromosomal level had no
effect, as determined by GFP-mediated fluorescence (Fig. 3B).
When agrA and sarA were restored in the respective agrA sarR
and sarA sarR double mutants, the agr P3 promoter exhibited
wild-type promoter activity similar to that found in the sarR
mutant, strongly implying that a deletion in sarR has no direct
role in influencing RNAIII transcription. RT-PCR of RNAIII
expression in these mutants and complemented mutants also
supported results of the promotion fusion studies (data not
shown). Collectively, these results clearly imply that AgrA pos-
itively regulates both agr P2 and P3 promoters, whereas SarR
impacts on P2 but not P3 transcription. While SarA also up-
regulates the P2 promoter, it is likely that the effect on the agr
P3 promoter may be indirect (i.e., via upregulation of RNAII
and subsequently AgrA), because the double sarA agr mutant,
similar to the single agr mutant, had little, if any, P3 promoter
activity.
The effect of AgrA box and SarA/SarR binding sites on agr
P2 and P3 transcription. To establish the crucial promoter
elements relevant to agr transcription, we focused on four
AgrA promoter boxes to which AgrA binds (32) as well as the
sarA and sarR binding sites shown to be important for agr
transcription (Fig. 1) (8, 24). As AgrA exists as a dimer (32)
and hence binds to two tandem AgrA promoter boxes (18), we
introduced transversion mutations on individual AgrA boxes
within each of the tandem AgrA boxes as well as truncation
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and transition mutations to the putative SarA and SarR bind-
ing sites between the P2 and P3 promoters (Fig. 4A). These
mutated and truncated promoters were then used to generate
modified agr P2 or P3 GFP reporter fusions in pALC1484
followed by introduction of these recombinant plasmids into
parental strain SH1000. We found that transversion mutations
to one of the proximal (box 1 or box 2) or distal (box 3 or box
4) AgrA boxes resulted in almost complete abolishment of the
agr P2 promoter activity, similar to what has been found with
the vector alone (Fig. 4B). A similar trend on the agr P2
promoter activity was also observed with truncation of the
putative SarA/SarR binding sites and the distal AgrA promoter
boxes, while the proximal AgrA boxes (short I) were left intact.
The transition mutation of the SarA binding sites (P2-SarA
site) also exhibited significantly reduced agr P2 activity, while
that of the SarR binding site mutation (P2-SarR site) led to a
higher level of agr P2 promoter activity than that of the parent
(Fig. 4B). Deletion of the distal AgrA promoter boxes (boxes
3 and 4 [short II]) also has a profound effect on diminishing the
agr P2 promoter activity. Collectively, these data suggest that
the regulatory control of the agr P2 promoter is more stringent
in that it requires multiple regulatory promoter elements, in-
cluding AgrA and SarA binding sites, to exhibit optimal agr P2
promoter activity.
We also studied the effects of these mutations on agr P3
promoter activity as determined by GFP fusions in strain
SH1000 (Fig. 4C). As has been reported previously (2, 4, 26),
the agr P3 promoter activity was significantly higher than the
agr P2 counterpart (Fig. 4C versus B). Mutation in one of the
proximal AgrA boxes (box 4 or box 3) resulted in an inactive
promoter, whereas a similar mutation in one of the distal AgrA
promoter boxes (box 2 or box 1) led to a moderate reduction
in agr P3 promoter activity compared with that of the parental
strain. Interestingly, elimination of both distal AgrA boxes
(boxes 1 and 2) as seen in the short IV promoter fragment
resulted in a reduction in agr P3 promoter activity, while mu-
tations in one of the distal AgrA boxes (box 2 or box 1) also
exhibited reduced agr P3 activity, but this activity level was still
higher than that of the agr mutant with the vector control.
Truncation of the SarA/SarR binding sites and the distal tan-
dem AgrA promoter boxes (short III) rendered the P3 pro-
moter less active than the short IV promoter fragment encom-
passing the SarA/SarR binding site but closer in activity to the
box 1 or box 2 mutant, thus indicative of the importance of the
SarA binding site in the presence of proximal tandem AgrA
boxes (short III versus short IV). Transition mutation of the
SarR binding site led to a pattern of P3 promoter activity
similar to that of the wild type, quite different from the effect
of this site on the P2 promoter (Fig. 4B and C). In contrast, the
transition mutation of the SarA binding site resulted in lower
P3 activity. Taken together, these results strongly suggest that
during the late stage of growth, active transcription of RNAIII
tends to overcome the requirement for SarA and is likely
dependent solely on AgrA activity, as evidenced by the absence
FIG. 2. Transcriptional analysis of the agr P2 promoter in assorted agrA, sarA, and sarR mutants during growth. (A) Real-time RT-PCR analysis
of the RNAII transcript during exponential (OD650  0.7), late exponential (OD650  1.1), and post-exponential (OD650  1.7) phases.
Transcription levels of the mutants are normalized to the gyrB transcript and are reported relative to transcriptions in the parental strain SH1000
(set to 1.0 at each of the ODs) at the identical ODs. The data are presented as the averages from three independent, real-time RT-PCR
experiments. The error bars represent standard deviations. (B) Transcriptional fusions of the 235-bp agr P2 promoter fused to the GFPuvr reporter
gene in pALC1484 in assorted mutants. The data are presented as fluorescence units (obtained at multiple time points) divided by OD650 values
as described in Materials and Methods. The error bars represent standard deviations. (C) Promoter GFP fusion of the agr P2 promoter in selected
complemented mutants during the post-exponential phase. The data are given as mean fluorescence units/OD650 values obtained from triplicate
samples. The experiments have been repeated at least three times, with the data presented as the means from three independent experiments. The
error bars represent standard deviations.
FIG. 3. Promoter fusion analysis of the agr P3 promoter in assorted
agrA, sarA, and sarR mutants during growth. (A) The 219-bp agr P3
promoter was fused to the GFPuvr reporter gene in pALC1484 in
assorted mutants. The data are presented as fluorescence units/OD650
values. The results are presented as the means from three independent
experiments, with the error bars representing standard deviations.
(B) Promoter GFP fusion of the agr P3 promoter in selected comple-
mented mutants during the postexponential phase. The data are given
as mean fluorescence units/OD650 values. The experiments have been
repeated at least three times, with the data presented as the means
from three independent experiments. The error bars represent stan-
dard deviations.
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of agr P3 promoter activity when the proximal AgrA box (box
3 or box 4) was mutated, even with the SarA binding site intact.
The binding affinity of SarR and SarA to the agr promoter
element. In previous studies, we have shown that the SarA
protein level reached its peak during the late exponential
phase and tapered toward the post-exponential phase (10) (see
Fig. SA in the supplemental material). In contrast, SarR pro-
tein expression tended to peak postexponentially, which we
implicated to be involved in the repression of sarA transcrip-
tion during the later stage of bacterial growth (23). Given this
discrepancy in peak expression profiles, we consider the plau-
sibility that SarA may act early on the agr P2 promoter during
the exponential phase to increase AgrA expression, while SarR
could downregulate the agr P2 promoter postexponentially. A
corollary for this scheme is that SarR must have a higher
binding affinity than SarA to the agr promoter, thus enabling
displacement of SarA from the agr P2 promoter as the intra-
cellular concentration of SarR increases. Accordingly, we con-
ducted gel shift assays of purified SarA or SarR with a radio-
labeled 102-bp agr promoter that encompasses the four AgrA
boxes and the SarA/SarR binding sites. As shown in Fig. 5A,
the gel shift pattern of SarR differed from that of SarA, with
multiple retarded complexes consistent with dimer-dimer in-
teractions (20, 24). Additionally, the Kd (dissociation constant)
of SarR to the agr promoter, as determined by the concentra-
tion of protein that shifted 50% of the probe, is 50 nM, much
lower than the Kd of SarA at 200 nM. This implies higher
SarR binding affinity to the agr promoter than SarA. To de-
termine if SarR can efficiently displace SarA from the agr
promoter fragment, we preincubated the radiolabeled agr pro-
moter fragment with SarA at a concentration close to the Kd
(150 nM) at room temperature for 20 min, followed by the
addition of increasing concentrations of SarR. As displayed in
Fig. 5B (left), the addition of 25 nM SarR to the reaction
mixture of SarA and the agr promoter fragment was able to
alter the gel shift pattern from that of SarA to SarR (see Fig.
5A). We also found that SarA could displace SarR from the agr
promoter in a similar fashion; however, this dislodgement of
SarR required a much higher concentration of SarA, beginning
at 150 nM (Fig. 5B, right). These data are consistent with the
notion that SarR binds with higher affinity to the agr promoter
than SarA and in all likelihood efficiently displaces SarA from
the agr promoter during the post-exponential phase, at a time
when the concentration of SarR is highest (23).
In vitro runoff transcription from the agr P2 promoter with
AgrA, SarA, and SarR. To assess the effect of AgrA, SarA, and
SarR on agr transcription in vitro, we first purified RNA poly-
merase (RNAP) from the triple agrA sarA sarR mutant of
SH1000 to eliminate any potential contamination of the core
RNAP with the above three transcription factors. Core RNAP
FIG. 4. The roles of AgrA promoter boxes and SarA/SarR binding sites in transcription from the agr P2 and P3 promoters in strain
SH1000 as determined by transcriptional fusions. (A) Schematics of the mutations and truncation of the agr P2 promoters in pALC1484 in
strain SH1000. An analogous scheme of the mutated and truncated P3 promoters was also constructed, except that the P3 promoter replaces
the P2 promoter, with the elements in reverse orientation (see Fig. SC in the supplemental material). In addition, the P3-short III is
analogous to P2-short I, and P3-short IV is similar to P2-short II. (B) Transcriptional fusions of the native, mutated, and truncated agr P2
promoter linked to GFPuvr in pALC1484 in SH1000. (C) Transcriptional fusions of the native, mutated, and truncated agr P3 promoter linked
to GFPuvr in pALC1484 in SH1000. The data in panels B and C are presented as the mean results from three independent experiments. The
error bars represent standard deviations.
FIG. 5. Gel shift assays (EMSA) of the agr promoter with SarA and
SarR. (A) EMSA with an end-labeled agr promoter fragment (10,000
cpm) in increasing concentrations of SarA or SarR. The agr promoter
fragment is 102 bp in length and comprises four AgrA boxes together
with the intervening sequence that contains the overlapping SarA/
SarR binding sites. The bold arrow points to the unbound agr probe.
(B, left) EMSA of the end-labeled 102-bp agr promoter fragment
(10,000 cpm) preincubated with 150 nM SarA for 20 min at room
temperature followed by the addition of increasing concentrations of
SarR; (right) EMSA of the agr promoter fragment preincubated with
50 nM SarR for 20 min at room temperature followed by the addition
of increasing concentrations of SarA. The filled arrow indicates un-
bound agr probe, while the empty arrow highlights the SarA promoter
complex; the three asterisks designate SarR-promoter complexes.
Multiple complexes of SarR with the agr promoter have been seen in
gel shift assays (23), presumably due to SarR dimer-dimer interactions.
EMSA of SarA and SarR with the control promoter fragment can be
found in Fig. SB in the supplemental material.
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was purified with a nickel column from the cell lysate of the
triple mutant containing a chromosomal copy of rpoC bearing
a C-terminal His tag as described in the experimental proce-
dures. SDS-PAGE analysis had confirmed the purity of the
core RNAP. Runoff transcription assays were then conducted
with a linearized DNA template of the agr P2 promoter con-
taining four AgrA boxes and the SarA/SarR binding sites. As
shown in Fig. 6A, AgrA alone, preincubated with 1 mM acetyl
phosphate, could promote transcription from the agr P2 pro-
moter, whereas its absence resulted in a very low level of
transcription (Fig. 6B, far left lane). The addition of increasing
concentrations of SarA to a fixed amount of AgrA resulted in
an increase in agr P2 transcription (Fig. 6A), thus indicating
that SarA can augment P2 transcription in the presence of
AgrA, whereas SarA alone led to a mild repression in agr P2
transcription (data not shown). Of interest, transcription from
the agr P2 promoter was inhibited by rising concentrations of
SarR, even in the presence of AgrA (Fig. 6B, right). More
importantly, P2 transcription, even in the presence of both
AgrA and SarA, was significantly inhibited by SarR in a dose-
dependent fashion (Fig. 6B, left).
DNA bending assays with SarA, SarR, and AgrA. One pos-
sibility by which SarA and/or SarR could modulate agr tran-
scription is with DNA bending (20, 21). Accordingly, recom-
binant pCY7, the bending vector (29) containing the fragment
with the SarA/SarR binding sites, was digested with EcoRI,
HindIII, BstNI, EcoRV, NheI, and BamHI to release the in-
sert (Fig. 7A). All fragments, 432 bp in length, were then end
labeled with [	-32P]ATP and evaluated by EMSA with SarA or
SarR (0.5 M). As shown in Fig. 7B, SarA was able to bend the
agr promoter fragment, with the mobility of the agr promoter
element being more retarded when the bend occurs at the
center than at the edge of the fragment. The relative mobility
of the complex with SarA bound in the middle (M) and near
FIG. 6. In vitro runoff transcription assays of the agr P2 promoter
with AgrA, SarA, and SarR. (A) The agr P2 promoter fragment was
incubated with AgrA (25 nM in acetyl phosphate) in the absence or
presence of SarA at increasing concentrations for 10 min at room
temperature. The amount of AgrA used in this assay was determined
by prior titration, showing increased agr P2 transcription with rising
concentrations of AgrA. RNAP, nucleotides, and [-32P]UTP were
added to the above reaction mixtures and allowed to incubate at 37°C
for 15 min, followed by the addition of stop solution as described in
Materials and Methods. The reaction mixtures were then resolved in
8% urea-PAGE gels, which were then dried and exposed to a phos-
phorimaging cassette. A single agr P2 transcript of the expected size
was generated with this assay. (B) Runoff transcription assay of the agr
P2 promoter with acetyl phosphate-treated AgrA with SarR and SarA
(left) or with SarR (right).
FIG. 7. DNA bending assays of the various agr promoter fragments
encompassing SarA/SarR or AgrA P2 tandem sites. (A) The bending
vector pCY7 (31) containing a duplicated region (arrows) separated by
a multicloning site into which paired oligonucleotides were cloned (see
Materials and Methods). Digestion of the recombinant vector with
various restriction enzymes results in fragments of identical lengths but
with the insert permutated with respect to the fragment ends.
(B) Bending assay performed with 0.5 nmol SarA and purified 5
end-labeled promoter fragments derived from pAM1163 digested with
EcoRI (E), HindIII (H), BstNI (T), EcoRV (V), NheI (N), or BamHI
(B). (C) Bending assay performed with 0.5 nmol SarR using the same
fragments as those described in panel A. Depending upon SarR con-
centration, EMSA of the agr promoter fragment with SarR can yield
three or four complexes, akin to what has been described in Fig. 5B;
however, the relative mobility of a specific complex was little changed
across the spectrum of restriction digests. (D) Bending assay per-
formed with 25 nmol AgrA on the purified 5 end-labeled fragments
derived from pAM1847 containing the AgrA tandem P2 site. The
addition of acetyl phosphate did not detectably alter the relative mo-
bility of the AgrA-promoter complex. Protein concentrations used in
each of the above-described assays (panels B to D) were determined
using pilot titrations.
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the edge of the DNA fragment (E) was determined and used
to calculate the bending angle () based on the following
equation: M/E  cos(/2) (38). With this method, we deter-
mined the bending angle of the agr promoter to be 79° when
SarA is bound. In contrast to SarA, there was little or no
bending of the agr promoter fragment containing the SarA/
SarR binding site with SarR (Fig. 7C), even at a concentration
of SarR that was 5-fold higher than that of SarA (data not
shown). We also determined the bending effect of AgrA on the
proximal tandem AgrA boxes of the agr P2 promoter (Fig. 7D).
In this scenario, AgrA also induced bending of the agr P2
fragment containing the proximal AgrA boxes, with the bend-
ing angle estimated to be 81°. The addition of acetyl phos-
phate to AgrA prior to incubation with the promoter fragment
did not alter the bending activity, thus implying that the effect
of phosphorylated AgrA is likely to activate the transcription
complex rather than altering the bending angle of the agr P2
promoter DNA.
DISCUSSION
Some of the well-described intracellular signaling molecules
that bind the agr promoter are AgrA, SarA, and SarR (25, 26).
AgrA, once activated via phosphorylation, binds as a dimer to
each of two 9-bp direct repeats within the P2-P3 promoter
region (see Fig. 1) (18, 32). SarA and SarR, on the other hand,
are dimers (20, 21) that recognize and bind to an overlapping
site between two AgrA binding direct repeats (Fig. 1) (9, 24).
To understand how these three signaling molecules interact at
the agr promoter, we undertook the current study to evaluate
the individual and combined effects of AgrA, SarA, and SarR
on agr P2 and P3 promoter activities.
To avoid any issues with polar effects and to differentiate this
study from prior studies, we have constructed all of our mu-
tants in SH1000 using pMAD (1), carefully deleting only the
coding regions without any antibiotic marker replacement and
leaving the promoters and transcription termination signals
intact. The use of SH1000, a strain with a restored copy of rsbU
and hence an intact sigB operon, is notable in this study, be-
cause previous studies on agr regulation by agrA, sarA, and sarR
have been conducted with strains 8325-4 or RN6390, both of
which are defective in rsbU. In addition, various complemented
mutants in this study were constructed by replacing the deleted
gene with a wild-type copy on the chromosome. We have also
verified by Northern blots that truncated transcripts of appro-
priate sizes were transcribed in the mutants. Using agrA, sarA,
sarR, double and triple mutants, and complemented mutants in
the SH1000 background, we have unequivocally shown that
AgrA is absolutely required for agr P2 and P3 transcription. In
distinction to previous data, we demonstrated here that the
transcriptional regulators SarR and SarA primarily affect the
agr P2 promoter to alter RNAII transcription (Fig. 2 and 3). As
RNAII encodes AgrA, which binds to the AgrA boxes to in-
fluence P3 transcription (18, 32), it is likely that the effect of
SarA and SarR on the P3 promoter is indirect and is mediated
via AgrA encoded by RNAII. This was confirmed by promoter
fusion studies of the agrA sarR mutant wherein the double
mutant exhibited little P2 and P3 activity, similar to that of the
agrA mutant (Fig. 2 and 3). Additionally, the sarA agr mutant
also displayed an almost negligible level of P2 and P3 promoter
activities, whereas the single sarA mutant exhibited an inter-
mediate level of P2 and P3 transcription between the parent
and the sarA agr double mutant. Restoration of agrA to the
agrA sarR double mutant and sarA to the sarA sarR double
mutant returned agr P2 transcription to the sarR mutant level,
which was much higher than that of the parental strain (Fig.
2C). In contrast to the agr P2 transcription, reconstitution of
agrA to the agrA sarR double mutant returned the P3 promoter
activity only to the wild-type level (Fig. 3B), thus implicating
AgrA, but not SarR, to be the crucial element in agr P3 tran-
scription. Accordingly, the major effect of AgrA on RNAII and
RNAIII promoters and the salient effect of SarA and SarR on
RNAII but not the RNAIII promoter are prominent features
of agr regulation in S. aureus.
Previous studies have identified two sets of direct repeats
within the agr P2-P3 promoter region where AgrA binds (18).
Nestled between the two sets of direct repeats are the palin-
drome and the overlapping inverted repeats to which winged
helix structures such as SarA and SarR bind, respectively (Fig.
1) (20, 21, 31). To dissect the contribution of these binding
sites to agr P2 and P3 transcription, we have mutated the AgrA
boxes and truncated and mutated the SarA/SarR binding site
of an agr promoter fragment on a plasmid carrying the GFPuvr
fusion in strain SH1000 (Fig. 4A). Our data clearly showed
distinct P2 and P3 activation profiles in response to these
mutations in the AgrA boxes. In particular, mutations of the
proximal (box 1 or box 2) and distal (box 3 or box 4) AgrA
boxes showed that all of the AgrA boxes where activated AgrA
binds are essential to transcription from the agr P2 promoter.
Mutation of the SarA binding site also reduced the P2 pro-
moter activity to a very low level, while a similar mutation in
the SarR binding site elevated P2 promoter activity to a degree
higher than that of the parental strain (Fig. 4B). As can be
observed in the sarR sarA mutant, this effect of sarR on the agr
P2 promoter is dependent on an intact agrA (Fig. 2B and C).
The scenario with the agr P3 promoter is very much different,
with the proximal AgrA box (box 3 or box 4) being more
important than the distal box (box 2 or box 1) in agr P3 tran-
scription (Fig. 4C). These data are in agreement with our
assertion that AgrA is the major effector of agr P3 transcrip-
tion.
Our results with agrA, sarA, and sarR mutants, coupled with
those of the mutated AgrA boxes, reinforced the notion that
the agr P2 and P3 promoters are regulated differentially, with
AgrA being the critical element in P3 transcription and SarA
and SarR, in conjunction with AgrA, being important to P2
transcription. This notion of differential regulation of agr P2
and P3 promoters was also supported by promoter activation
studies in the rabbit endocarditis model, where P3 promoter
activation appears to differ from P2 activation (37).
We have previously found that SarA and SarR protein ex-
pression varies during growth, with SarA expressed maximally
during the late exponential phase (10) and SarR peaking post-
exponentially (23). The growth-phase-dependent expression of
SarA described here differed from the data of Fujimoto et al.,
wherein they described SarA as being constant during all
stages of growth (12). This discrepancy may be due to their use
of rabbit anti-SarA polyclonal antibodies, which may have
other native anti-S. aureus antibodies; in contrast, our Western
blot was developed with a murine anti-SarA monoclonal anti-
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body (see the supplemental data). As SarR and SarA bind to
overlapping sequences on the agr promoter, we conceptualized
that SarR may have a higher binding affinity to the agr pro-
moter than SarA, thus allowing displacement of SarA from the
agr promoter in transition from the late exponential phase to
the post-exponential phase. For EMSA analysis with the agr P2
promoter, we have elected to use the unphosphorylated form
of SarA, because we have found that a pknB mutant of SH1000
exhibited a higher level of RNAII expression than the parent
(35), thus implying that the unphosphorylated form of SarA
may be more active on the agr P2 promoter than the phos-
phorylated counterpart. Using these proteins, we have found
that SarR indeed has a lower Kd for the agr P2 promoter than
SarA, thus implying higher binding affinity of SarR to the agr
promoter than that of SarA. Competition assays with SarR
added to a preincubated mixture of SarA with an agr promoter
fragment also validated successful displacement of SarA by
SarR at 50 nM, while the corresponding assay with SarA
displacing SarR necessitated a much higher concentration of
150 nM (Fig. 5B).
In contrast to agr P3 transcription, we have shown that both
SarA and SarR required AgrA to exert its activation and re-
pression of the agr P2 promoter, respectively. To validate this
finding, we purified core RNAP from a triple agrA sarA sarR
mutant of SH1000 to steer clear of any prior contamination of
RNAP with these three transcription factors. Using this
RNAP, we found that acetyl phosphate-treated AgrA can ac-
tivate transcription from the agr P2 promoter (Fig. 6). This
activation can be further enhanced by SarA in a dose-depen-
dent fashion. Importantly, this finding contrasts with the data
from Chakrabarti and Misra, who reported that SarA represses
agr P2 transcription (3). This discrepancy can be explained by
the fact that SarA likely activates agr P2 transcription only in
the presence of AgrA. In the absence of AgrA, we also found
that SarA can repress agr P2 transcription in a dose-dependent
fashion. Interestingly, SarR can repress agr P2 transcription in
the presence of AgrA alone or a combination of AgrA and
SarA (Fig. 6B). These data, together with those from the sarR
mutant, highlighted the repressive role of SarR in the presence
of AgrA and SarA under conditions that more likely reflect the
scenario in vivo.
We have also conducted the agr promoter bending assay
with these proteins. Interestingly, SarA, but not SarR, was able
to induce bending of the agr promoter fragment comprising the
SarA/SarR binding sites (Fig. 7), with the estimated bending
angle of the agr promoter fragment induced by SarA alone to
be 80°. We also observed that AgrA could induce 80°
bending of the tandem AgrA boxes (box 1 and box 2) proximal
to the agr P2 promoter. Notably, Sidote et al. observed in
crystallization studies that the C-terminal DNA binding do-
main of AgrA, as a monomer, bends a single 9-bp agrA pro-
moter fragment 40° (32). Our data here suggest that AgrA,
as a dimer, can provoke additional bending upon binding to
the tandem repeat of AgrA boxes. Conceivably, induced bend-
ing of the agr P2 promoter comprising the tandem AgrA boxes
and the SarA/SarR binding sites would be close to 160° or
higher, given the limits of approximation in these assays. These
data, together with those from EMSA and in vitro transcription
assays, suggest a model whereby SarA and SarR can modulate
transcription from the agr P2 promoter via interaction with
AgrA on the agr promoter (Fig. 8). AgrA dimer, by virtue of its
binding to each of the tandem AgrA boxes to induce DNA
bending (32), is the main driving force behind agr P2 and P3
transcription. While AgrA is the requisite factor for agr P3
FIG. 8. A proposed model for the regulation of the agr P2 promoter by AgrA, SarA, and SarR. For the P2 promoter, the major transcription
factor is the AgrA dimer, which binds to the tandem AgrA boxes to induce 80° bending (Fig. 7). Binding of SarA will introduce additional bending
(80° by SarA alone) to that induced by AgrA to allow interaction of two AgrA dimers anchored at two tandem AgrA boxes, thus enhancing
efficient recruitment of RNAP to initiate transcription. SarR binds with a higher affinity than SarA to an overlapping site on the agr promoter site.
Accordingly, SarR, upon accumulation during the transition from late exponential to post-exponential phase, displaces SarA from the agr
promoter. However, in contrast to SarA, SarR binds but does not bend significantly, thus precluding more active engagement of RNAP. As a result,
there is downregulation of transcription from the agr P2 promoter due to SarR. In the case of the agr P3 promoter, the sole and required
transcription factor is AgrA. SarA and SarR can contribute to this effect by modulating agrA expression via activation or repression of RNAII.
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transcription, the scenario with agr P2 transcription is quite
different, with two AgrA dimers first binding to two sets of
tandem AgrA boxes to induce bending of the agr promoter
(Fig. 7) (18, 32) to facilitate P2 transcription. During the ex-
ponential phase, the SarA protein level increases (10), leading
to binding of the SarA dimer to the SarA binding site situated
between the two tandem AgrA boxes (21). Binding of SarA
induces additional bending of the agr P2 promoter (Fig. 7 and
8), presumably more than that of AgrA alone, thus further
enhancing transcriptional activation of the agr P2 promoter by
RNA polymerase (Fig. 6A). We surmise that this enhancement
may be due to additional interaction of the two AgrA dimers
anchored on two sets of tandem AgrA boxes (Fig. 8), facili-
tated by the 160° bending of the agr promoter by SarA and
AgrA. In transition from the late exponential phase to the
post-exponential phase, the SarR protein accumulates (23). As
the SarR protein binds to the agr promoter with higher affinity
than SarA, it would displace the SarA bound on the agr pro-
moter (see Fig. 5B). In contrast to SarA, SarR binds but does
not induce bending of the agr promoter, possibly unwrapping
the transcription competent complex, thus leading to down-
regulation of transcription from the agr P2 promoter.
While our model does not support direct modulation of the
agr P3 promoter by SarR and SarA, it does not preclude indi-
rect effects whereby SarA and SarR would activate and repress
the agr P2 promoter, respectively, to modulate AgrA expres-
sion, which in turn would dictate transcription from the P3
promoter.
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